Literature DB >> 15362655

Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground.

David Nolan, Silvana Gaudieri, Mina John, Simon Mallal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362655     DOI: 10.1097/00002030-200406180-00001

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.

Authors:  Viviane D Lima; Valeria Fink; Benita Yip; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

2.  Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS.

Authors:  Alex Soriano; Francisco Lozano; Harold Oliva; Felipe García; Meritxell Nomdedéu; Elisa De Lazzari; Carmen Rodríguez; Alicia Barrasa; José I Lorenzo; Jorge Del Romero; Montserrat Plana; José M Miró; José M Gatell; Jordi Vives; Teresa Gallart
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

3.  Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.

Authors:  Jianming Tang; Wenshuo Shao; Yun Joo Yoo; Ilene Brill; Joseph Mulenga; Susan Allen; Eric Hunter; Richard A Kaslow
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 4.  Immune pathogenesis of pediatric HIV-1 infection.

Authors:  Caroline T Tiemessen; Louise Kuhn
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

Review 5.  Immunogenetic determinants of heterosexual HIV-1 transmission: key findings and lessons from two distinct African cohorts.

Authors:  Jianming Tang
Journal:  Genes Immun       Date:  2021-05-01       Impact factor: 2.676

6.  Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.

Authors:  Hemant Kulkarni; Vincent C Marconi; Brian K Agan; Carole McArthur; George Crawford; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.